Covered recipient · General Payments record
JULIE D BOGDAN
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2022
$477.50
- Reported across 26 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $351.24 | 17 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $170.33 | 5 |
| Takeda Pharmaceuticals U.S.A., Inc. | $50.24 | 3 |
| Amgen Inc. | $44.35 | 3 |
| PFIZER INC. | $43.16 | 3 |
| Lilly USA, LLC | $25.82 | 2 |
| IBSA Pharma Inc. | $17.34 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.91 | 04/05/2022 | Food and Beverage | Undisputed | 01/23/2026 | 893432707 | CMS |
| ABBVIE INC. | $27.54 | 04/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 893432709 | CMS |
| ABBVIE INC. | $106.23 | 05/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | 893432711 | CMS |
| ABBVIE INC. | $10.47 | 07/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | 893432713 | CMS |
| ABBVIE INC. | $8.18 | 11/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | 893432715 | CMS |
| Amgen Inc. | $14.87 | 03/31/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939517153 | CMS |
| Amgen Inc. | $15.48 | 04/28/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939517151 | CMS |
| Amgen Inc. | $14.00 | 08/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939517155 | CMS |
| IBSA Pharma Inc. | $17.34 | 11/02/2022 | Food and Beverage | Undisputed | 01/23/2026 | 890016549 | CMS |
| Lilly USA, LLC | $12.99 | 07/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918515393 | CMS |
| Lilly USA, LLC | $12.83 | 09/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918519747 | CMS |
| PFIZER INC. | $13.20 | 03/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 949297207 | CMS |
| PFIZER INC. | $14.96 | 05/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 949263597 | CMS |
| PFIZER INC. | $15.00 | 06/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | 949285297 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.64 | 02/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 955918909 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.81 | 03/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | 955918913 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.79 | 04/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | 955918917 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022
- Source files
- Dataset page · Bulk file · PY2021 , PY2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.